German Cancer Research Center

This early-phase trial tests a new vaccine called PANHPVAX in 45 healthy adults aged 18-45. The vaccine targets a part of the HPV virus (L2 antigen) to potentially protect against multiple HPV types. The main goal is to check safety and how well the body's immune system responds …

This study tests whether using a patient's unique genetic information to choose their cancer treatment leads to better results than standard care. About 946 adults with advanced rare cancers will be randomly assigned to either immediate personalized treatment or standard treatmen…

The CATCH trial is a large observational study for people with metastatic breast cancer. It uses advanced genetic testing on tumor biopsies to find unique biomarkers and drug targets. The goal is to create a precision medicine platform that helps guide patients toward the most pr…